Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know

Moderna (MRNA) concluded the recent trading session at $49.56, signifying a -7.49% move from its prior day's close.

27.03.2026

ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?

IBRX and MRNA hinge on single-drug success, but pipeline depth, growth plans and risks set them apart in the race for biotech upside.

26.03.2026

2 Healthcare Stocks That Could Soar Over the Next 5 Years

These two biotechs could ride the wave of significant clinical progress. However, both carry above-average risk.

25.03.2026

Moderna Stock is Soaring. Is It Too Late to Buy?

Moderna's first big success was its coronavirus vaccine -- that product brought in $18 billion in revenue at its peak. The biotech recently submitted a flu vaccine candidate to regulators.

20.03.2026

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, Moderna (MRNA) closed at $51.38, marking a -1.89% move from the previous day.

19.03.2026

Pfizer vs Moderna: Which Pharma Stock Has More Upside?

The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes with a healthy dose of risk.

17.03.2026

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

The first severe case of the virus has been detected in New York.

Videolar

13.02.2026

Neutral

MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

04.02.2026

Positive

CANCER BREAKTHROUGH: Moderna, Merck report cancer discovery

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
MRNA	Barclays	Equal Weight	undefined >> $25	January 28th 2026
MRNA	UBS	Neutral	undefined >> $34	January 7th 2026
MRNA	Jefferies	Hold	undefined >> $30	December 12th 2025
MRNA	Citigroup	Neutral	undefined >> $40	March 13th 2025

Moderna, Inc. (MRNA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating